Autres langues Neogen Corporation

Actions

NEOG

US6404911066

Equipement, fournitures et distribution médicale

Temps réel estimé Cboe BZX Autres places de cotation 17:14:02 29/07/2026			Varia. 5j.	Varia. 1 janv.
9,115 ^USD	-0,82%		-7,48%	+30,11%

18/06	Neogen Corporation étend la disponibilité des recommandations de la section 2(ee) de la FIFRA pour ses produits Prozap Insectrin X Concentrate et Prozap Screw Worm and Ear Tick Aerosol	CI
18/06	Neogen étend ses recommandations FIFRA au Texas et à la Floride	MT

Autres langues

20/07	Neogen to Release Fourth-Quarter Fiscal Year 2026 Financial Results on July 30, 2026
17/07	Zoetis' acquisition of Neogen Genomics requires Phase 2 review
19/06	Neogen Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight against New World Screwworm
18/06	Neogen Corporation Expands Availability Of FIFRA Section 2(ee) Recommendations for Prozap Insectrin X Concentrate and Prozap Screw Worm and Ear Tick Aerosol
18/06	Neogen Expands Availability of FIFRA Recommendations to Texas, Florida
18/06	Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World Screwworm
23/04	Neogen’s Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ Certification
09/04	Tranche Update on Neogen Corporation's Equity Buyback Plan announced on October 10, 2018.
09/04	Neogen Corporation Raises Earnings Guidance for the Full Fiscal Year 2026
09/04	Neogen Shares Rise After Fiscal Q3 Results Beat Estimates, Full-Year Sales Outlook Raised
09/04	Neogen(R) Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary
09/04	Neogen Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026
09/04	Stocks Decline Pre-Bell Amid Uncertainty Over US-Iran Truce; Key Inflation Report on Deck
09/04	Neogen : 3Q FY2026 Earnings Call
09/04	Neogen Fiscal Q3 Adjusted Earnings, Revenue Fall; Full-Year Sales Outlook Raised
09/04	(NEOG) Neogen Expects Fiscal 2026 Revenue Range $857M - $860M, vs. FactSet Est of $850.6M
09/04	Neogen : Third Quarter 2026 Press Release
09/04	Neogen : Third Quarter 2026 Presentation
09/04	Neogen: Fiscal Q3 Earnings Snapshot
09/04	Earnings Flash (NEOG) Neogen Posts Fiscal Q3 Revenue $211.2M, vs. FactSet Est of $204.5M
09/04	Earnings Flash (NEOG) Neogen Posts Fiscal Q3 Adjusted EPS $0.09, vs. FactSet Est of $0.06
09/04	Neogen Reports Third Quarter Fiscal Year 2026 Financial Results
08/04	Neogen Corporation Appoints Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary
08/04	Neogen® Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary
01/04	Bruker Corporation Announces Appointment of Thierry L. Bernard to Its Board of Directors, Effective April 1, 2026